RT Journal Article
SR Electronic
T1 Lipid trajectories improve risk models for Alzheimer's disease and mild cognitive impairment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.27.24314494
DO 10.1101/2024.09.27.24314494
A1 Chase, Bruce A
A1 Frigerio, Roberta
A1 Yucus, Chad J
A1 Patel, Smita
A1 Maraganore, Demetrius M
A1 Sanders, Alan R
A1 Duan, Jubao
A1 Markopoulou, Katerina
YR 2024
UL http://medrxiv.org/content/early/2024/09/28/2024.09.27.24314494.abstract
AB To assess the relationship between lipids and cognitive dysfunction, we retrospectively analyzed blood lipid levels in clinically well characterized individuals with stable mild cognitive impairment (MCI) or Alzheimer's disease (AD) over the decade prior to first cognitive symptoms. In this case/control cohort study, AD and MCI cases were diagnosed using DSM.IV criteria; MCI cases had not progressed to dementia for 5 years; and controls were propensity matched to cases at age of symptom onset (MCI: 116 cases, 435 controls; AD: 215 cases, 483 controls). Participants were grouped based on longitudinal trajectories and quintile of variability independent of the mean (VIM) for total cholesterol, HDLC, LDLC, nonHDLC and ln(triglycerides). Models for the risk of cognitive dysfunction evaluated trajectory and VIM groups, APOE genotype, polygenic risk scores (PRS) for AD and lipid levels, age, comorbidities, and longitudinal correlates of blood-lipid concentrations. Lower HDLC trajectories (OR = 3.8, 95% CI = 1.3, 11.3) and the lowest VIM quintile of nonHDLC (OR = 2.2, 95% CI = 1.3, 3.0) were associated with higher MCI risk. Lower HDLC trajectories (OR = 3.0, 95% CI = 1.6, 5.7) and the lowest VIM quintile of total cholesterol (OR = 2.4, 95% CI = 1.5, 3.9) were associated with higher AD risk. The inclusion of lipid-trajectory and VIM groups improved risk-model predictive performance independent of APOE genotype or PRS for AD and lipid levels. These results provide an important real world perspective on the influence of lipid metabolism and blood lipid levels on the development of stable MCI and AD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis development of the structured clinical documentation support toolkits within the electronic health record was funded by the Agency for Healthcare Research and Quality (R01HS024057) to DM and the generous support of the Auxiliary of NorthShore University HealthSystem (now Endeavor Health). The analyses presented in this work were funded by the National Institute on Aging (R01AG081374 and R01AG063175) to JD. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The DodoNA project was approved by the NorthShore University HealthSystem Institutional Review Board (EH10-139, April 2011) and the studies in this work abide by the Declaration of Helsinki principles.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSummary statistics are available from the corresponding author upon reasonable request, following institutional approval.